Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 64, Issue 7, 2012, Pages 2104-2113

  Gao, Wei ^b   Sweeney, Catherine ^b   Connolly, Mary ^b   Kennedy, Aisling ^b   Ng, Chin Teck ^a,b   McCormick, Jennifer ^b   Veale, Douglas J ^b   Fearon, Ursula ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLOXALYLGLYCINE; GAMMA SECRETASE INHIBITOR; GELATINASE A; HAIRY RELATED TRANSCRIPTION FACTOR 1; HAIRY RELATED TRANSCRIPTION FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIGAND DELTA LIKE PROTEIN 4; NOTCH1 RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTHROSCOPY; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; DOWNSTREAM PROCESSING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; MICROVASCULAR ENDOTHELIAL CELL; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM;

ANOXIA; ARTHRITIS, RHEUMATOID; CELL MOVEMENT; ENDOTHELIAL CELLS; FEMALE; HUMANS; KNEE JOINT; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, NOTCH1; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863195085     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34397     Document Type: Article

References (50)

1. Kraan MC, Haringman JJ, Weedon H, Barg EC, Smith MD, Ahern MJ, et al. T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004;63:483-8. (Pubitemid 38530189)
2. Walsh DA, Pearson CI. Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res 2001;3:147-53. (Pubitemid 32303431)
3. Koch AE. Angiogenesis: implications for rheumatoid arthritis [review]. Arthritis Rheum 1998;41:951-62. (Pubitemid 28265398)
4. Kennedy A, Ng CT, Biniecka M, Saber T, Taylor C, O'Sullivan J, et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010;62:711-21.
5. Schoettler N, Brahn E. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis. Curr Opin Investig Drugs 2009;10:425-33.
6. Iso T, Hamamori Y, Kedes L. Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 2003;23:543-53. (Pubitemid 36438065)
7. Weinstein BM, Lawson ND. Arteries, veins, Notch, and VEGF. Cold Spring Harb Symp Quant Biol 2002;67:155-62. (Pubitemid 36775507)
8. Lai EC. Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins. EMBO Rep 2002;3:840-5. (Pubitemid 35154108)
9. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 2003;194: 237-55. (Pubitemid 36176887)
10. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum 1970;13:769-76.
11. Sivakumar B, Akhavani MA, Winlove CP, Taylor PC, Paleolog EM, Kang N. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg Am 2008;33:49-58. (Pubitemid 351193088)
12. Akhavani MA, Madden L, Buysschaert I, Sivakumar B, Kang N, Paleolog EM. Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther 2009;11:R64.
13. Ng CT, Biniecka M, Kennedy A, McCormick J, Fitzgerald O, Bresnihan B, et al. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 2010;69:1389-95.
14. Biniecka M, Kennedy A, Fearon U, Ng CT, Veale DJ, O'Sullivan JN. Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis 2009;69: 1172-8.
15. Kennedy A, Ng CT, Chang TC, Biniecka M, O'Sullivan JN, Heffernan E, et al. Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia. Arthritis Rheum 2011;63:923-32.
16. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, et al. Hypoxia requires Notch signaling to maintain the undifferentiated cell state. Dev Cell 2005;9:617-28. (Pubitemid 41555144)
17. Diez H, Fischer A, Winkler A, Hu CJ, Hatzopoulos AK, Breier G, et al. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 2007;313:1-9. (Pubitemid 44958449)
18. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 2008;105:6392-7. (Pubitemid 351758356)
19. Karlsson C, Jonsson M, Asp J, Brantsing C, Kageyama R, Lindahl A. Notch and HES5 are regulated during human cartilage differentiation. Cell Tissue Res 2007;327:539-51. (Pubitemid 46232324)
20. Zhou D, Udpa N, Gersten M, Visk DW, Bashir A, Xue J, et al. Experimental selection of hypoxia-tolerant Drosophila melanogaster. Proc Natl Acad Sci U S A 2011;108:2349-54.
21. McEvoy AN, Bresnihan B, Fitzgerald O, Murphy EP. Corticotropin- releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway. Ann N Y Acad Sci 2002;966:119-30. (Pubitemid 34729168)
22. Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y, et al. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res 2007;100:70-8. (Pubitemid 46066775)
23. Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999;42:1481-4. (Pubitemid 30265607)
24. Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003;30:260-8. (Pubitemid 36152587)
25. Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003;62 Suppl II:ii60-7.
26. Los M, Roodhart JM, Voest EE. Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist 2007;12:443-50. (Pubitemid 46698722)
27. Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. J Clin Invest 1999;103: 47-54. (Pubitemid 29031162)
28. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009; 15:232-9.
29. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009;15:220-31.
30. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62. (Pubitemid 40093472)
31. Lee JH, Suk J, Park J, Kim SB, Kwak SS, Kim JW, et al. Notch signal activates hypoxia pathway through HES1-dependent SRC/ signal transducers and activators of transcription 3 pathway. Mol Cancer Res 2009;7:1663-71.
32. Del Rey MJ, Izquierdo E, Caja S, Usategui A, Santiago B, Galindo M, et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1α/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 2009;60:2926-34.
33. Ottino P, Finley J, Rojo E, Ottlecz A, Lambrou GN, Bazan HE, et al. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: involvement of cytosolic phospholipase A2 activity. Mol Vis 2004;10: 341-50. (Pubitemid 41358265)
34. Coleman ML, McDonough MA, Hewitson KS, Coles C, Mecinovic J, Edelmann M, et al. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J Biol Chem 2007;282:24027-38. (Pubitemid 47328043)
35. Zheng X, Linke S, Dias JM, Gradin K, Wallis TP, Hamilton BR, et al. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci U S A 2008;105:3368-73. (Pubitemid 351723559)
36. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005; 24:5552-60. (Pubitemid 43119350)
37. Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol 2004;6:547-54. (Pubitemid 38786598)
38. Simonetti O, Lucarini G, Goteri G, Zizzi A, Biagini G, Lo Muzio L, et al. VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study. Int J Immunopathol Pharmacol 2006;19: 751-60. (Pubitemid 46145039)
39. Goedkoop AY, Kraan MC, Picavet DI, de Rie MA, Teunissen MB, Bos JD, et al. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res Ther 2004;6:R326-34.
40. Veale D, Rogers S, Fitzgerald O. Immunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skin. Br J Dermatol 1995;132:32-8.
41. Markham T, Mullan R, Golden-Mason L, Rogers S, Bresnihan B, FitzGerald O, et al. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J Am Acad Dermatol 2006;54:1003-12.
42. Canete JD, Pablos JL, Sanmarti R, Mallofre C, Marsal S, Maymo J, et al. Antiangiogenic effects of anti-tumor necrosis factor αtherapy with infliximab in psoriatic arthritis. Arthritis Rheum 2004;50:1636-41. (Pubitemid 38608086)
43. Park M, Yaich LE, Bodmer R. Mesodermal cell fate decisions in Drosophila are under the control of the lineage genes numb, Notch, and sanpodo. Mech Dev 1998;75:117-26. (Pubitemid 28423691)
44. Tallquist MD, Soriano P, Klinghoffer RA. Growth factor signaling pathways in vascular development. Oncogene 1999;18:7917-32. (Pubitemid 30066237)
45. Kojika S, Griffin JD. Notch receptors and hematopoiesis. Exp Hematol 2001;29:1041-52. (Pubitemid 32782638)
46. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 2001;108: 161-4. (Pubitemid 32918185)
47. Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007;445: 776-80. (Pubitemid 46279716)
48. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-78. (Pubitemid 46823443)
49. Morga E, Mouad-Amazzal L, Felten P, Heurtaux T, Moro M, Michelucci A, et al. Jagged1 regulates the activation of astrocytes via modulation of NFκB and JAK/STAT/SOCS pathways. Glia 2009;57:1741-53.
50. Nakazawa M, Ishii H, Nakamura H, Yoshino SI, Fukamizu A, Nishioka K, et al. NFκB2 (p52) promoter activation via Notch signaling pathway in rheumatoid synoviocytes. Int J Mol Med 2001;7:31-5.